Fast Track Initiative
Fast Track Initiative is a venture capital firm that focuses on investments in early and seed stage companies.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Fast Track Initiative Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
5,464,006Website Global Rank
1,701Website Monthly Traffic
Twitter Followers
Description
Fast Track Initiative is a venture capital firm that focuses on investments in early and seed stage companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2022 | reverSASP | Seed Round | - |
| 3/2022 | Modulus Discovery | Series C | 20.4M |
| 6/2022 | mediPhone | Series A | 8.1M |
| 8/2021 | FastDOCTOR | Series A | - |
| 11/2018 | mediPhone | Venture Round | - |
| 4/2019 | Modalis Therapeutics | Series B | 25M |
| 7/2017 | NIL Japan | Venture Round | 1.4M |
| 8/2022 | Varinos | Series C | - |
| 5/2020 | Modulus Discovery | Series B | 25.5M |
| 3/2016 | Braizon Therapeutics, Inc. | Series A | - |
| 8/2018 | Braizon Therapeutics, Inc. | Series B | 5.8M |
| 1/2009 | BrightPath Biotherapeutics | Funding Round | - |
| 2/2007 | Japan Medical Information Research Institute | Seed Round | - |
| 7/2017 | HanaVax | Seed Round | - |
| 12/2019 | RIN Institute | Venture Round | 1.8M |
| 6/2021 | Sonire Therapeutics | Series A | 0 |
| 8/2019 | Cytlimic | Series B | 12.3M |
| 12/2016 | Cytlimic | Seed Round | - |
| 11/2018 | PENTAS | Venture Round | - |
| 7/2018 | RIN Institute | Venture Round | - |
| 9/2019 | FastDOCTOR | Series A | - |
| 5/2005 | Chiome Bioscience | Funding Round | - |
| 5/2019 | RIN Institute | Venture Round | 1.8M |
| 1/2018 | AccuRna | Series B | 4.7M |
| 2/2008 | ProbeX | Seed Round | - |
| 3/2016 | ReasonWhy | Series A | 1.4M |
| 7/2017 | Mentalhealth Technologies | Venture Round | 1.4M |
| 7/2018 | HanaVax | Seed Round | - |
| 12/2016 | Cytlimic | Series A | 8.5M |
| 8/2018 | Modulus Discovery | Series A | 0 |
| 12/2019 | AccuRna | Series B | 2.3M |
| 10/2017 | Veldt | Seed Round | 994.2k |
| 8/2018 | YUKASHIKADO | Venture Round | 1.8M |
| 1/2009 | CellSeed | Venture Round | 9.1M |
| 10/2017 | Modalis Therapeutics | Series A | 8M |
| 5/2018 | NB Health Laboratory Japan | Venture Round | 3.3M |
| 3/2016 | AccuRna | Seed Round | - |
| 12/2022 | Storm Therapeutics | Series B | 30M |
| 2/2022 | A10 Lab | Series A | 0 |
| 10/2016 | NB Health Laboratory Japan | Venture Round | 1.9M |
| 12/2017 | Veldt | Seed Round | 1.4M |
| 6/2019 | PuREC | Series A | 5.4M |
| 11/2018 | Mentalhealth Technologies | Venture Round | 2.2M |
| 4/2020 | Mentalhealth Technologies | Venture Round | 2.2M |
| 9/2020 | LUCA Science | Series A | 0 |
| 1/2016 | PuREC | Seed Round | 759.2k |
| 7/2021 | Braizon Therapeutics, Inc. | Series B | 9.5M |
| 3/2021 | Metagen Therapeutics | Seed Round | 0 |
| 6/2018 | CellBank | Venture Round | - |
| 4/2017 | ReasonWhy | Venture Round | 3.7M |
| 6/2022 | LUCA Science | Series B | 29.2M |
| 3/2022 | Celsius Therapeutics | Series B | 0 |
| 9/2005 | CellSeed | Venture Round | 9M |
| 1/2019 | Veldt | Series B | - |
| 7/2022 | reverSASP | Seed Round | - |
| 6/2022 | mediPhone | Series A | 0 |
| 6/2022 | LUCA Science | Series B | 0 |
| 3/2022 | Celsius Therapeutics | Series B | 0 |
| 3/2022 | Modulus Discovery | Series C | 0 |
| 2/2022 | A10 Lab | Series A | 0 |
| 8/2021 | FastDOCTOR | Series A | - |
| 7/2021 | Braizon Therapeutics, Inc. | Series B | 0 |
| 6/2021 | Sonire Therapeutics | Series A | 0 |
| 3/2021 | Metagen Therapeutics | Seed Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
